To don Eureka is to experience absolute dexterity, comfort fitting and all the properties of a quality nitrile glove, everytime.
| Reorder Code | Size |
|---|---|
| NTR61XS | X-Small |
| NTR61SS | Small |
| NTR61MM | Medium |
| NTR61LL | Large |
| NTR61XL | X-Large |
Eureka Nitrile Exam Gloves
View Product
> Fingertip textured
> Powder Free
> Not made with natural rubber latex
> Chemotherapy drugs tested
> Lab chemical tested
> Ambidextrous
> Standard Cuff
> Dark blue colour
| Glove Properties | Measurement (mm) |
|---|---|
| Length | ≥230 |
| Thickness at Palm (centre of Palm) | ≥0.05 |
| Thickness at Finger (13mm ± 3mm from tip) | ≥0.07 |
| Physical Properties | Before Ageing | After Ageing |
|---|---|---|
| Tensile Strength (MPa) | ≥14 | ≥14 |
| Elongation (%) | ≥500 | ≥400 |
| Inspection Levels and AQL | Inspection Level | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4.0 |
| Tensile Strength | S2 | 4.0 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4.0 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Packaging | |
|---|---|
| Configuration | 300 gloves per box for XS to L 270 gloves per box for XL 10 boxes per carton |
| Regulatory Compliance | |
|---|---|
| Regulations | ARTG 164563 FDA 510(k) MDD 93/42/EEC REACH ROHS Directive 2002/95/EC EU 10/2011 EC 1935/2004 EU 2016/425 |
| International Standards | |
|---|---|
| Standards | ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 EN 16523-1 EN ISO 374-1 (Type C) EN 374 part 2, 4 & 5 EN 420 EN 455 part 1, 2 & 3 CEN/TS 14234 EN 13130 EN 1186 ISO 10993 part 5 & 10 HACCP Certified |
| Manufacturing Accreditations | |
|---|---|
| Accreditations | ISO 9001 ISO 13485 EN ISO 13485 |
| Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05, Test Report PN 128134A) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 7.3 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 20.6 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Eureka nitrile glove at 7.3 minutes and 20.6 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision. | |
